Reports of adverse effects of selective serotonin re-uptake inhibitors in Belgium and the Netherlands;Meldingen van vermoedelijke bijwerkingen van selectieve serotonine-heropnameremmers in Belgie en Nederland

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 36, 1996, Pages 1817-1820

  Van Ermen, A M C ^a   Ottervanger, J P ^b   Roisin, T ^a   Kurz, X ^a   Stricker, B H Ch ^b,c  

^a Ministerie Van Sociale Zaken   (Belgium)

^b Sectie Geneesmiddelenbewaking   (Netherlands)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANXIETY NEUROSIS; ARTICLE; BELGIUM; DEPRESSION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; GASTROINTESTINAL DISEASE; HUMAN; NETHERLANDS; RASH; SIDE EFFECT;

1-NAPHTHYLAMINE; ADULT; AGED; ANTIDEPRESSIVE AGENTS; BELGIUM; FEMALE; FLUOXETINE; FLUVOXAMINE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 0029798931     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Stricker BHCh. Bijwerkingen van geneesmiddelen: de causaliteits-beoordeling. Ned Tijdschr Geneeskd 1989,133:275-80.
2. Wiholm BE, Olsson S, Moore N, Wood S. Spontaneous reporting systems outside the United States. In. Strom BL, editor. Pharmaco-epidemiology 2nd ed. Chichester: Wiley, 1994:139-55.
3. Jeffries J, Bezchlibnyk-Butler K, Remington G. Amenorrhea and galactorrhea associated with fluvoxamine in a loxapine-treated patient [letter]. J Clin Psychopharmacol 1992;12:296-7.
4. Bronzo MR, Stahl SM. Galactorrhea induced by sertraline [letter]. Am J Psychiatry 1993;150:1269-70.
5. Skowron DM Stimmel GL. Antidepressants and the risk of seizures. Pharmacotherapy 1992:12:18-22.
6. Vincenti GE. Fluvoxamine and epilepsy [letter]. Lancet 1990;336: 947.
7. Coulter DM, Pillans PI. Fluoxetine and extrapyramidal side effects. Am J Psychiatry 1995;152:122-5.
8. Safety of fluoxetine. Comparison with fluvoxamine. Current Problems 1992;34:3
9. Choo V. Paroxetine and extrapyramidal reactions. Lancet 1993;341. 624.
10. Altshuler LL, Pierre JM, Wirshing WC, Ames D. Sertraline and akathisia [letter]. J Clin Psychopharmacol 1994;14:278-9.
11. Opler LA. Sertraline and akathisia. Am J Psychiatry 1994:151 620-1.
12. Shihabuddin L, Rapport D. Sertraline and extrapyramidal side effects [letter]. Am J Psychiatry 1994;151:288.
13. Hoaken PCS An alert to extrapyramidal side-effects from SSRIs [letter]. Can J Psychiatry 1995:40:51.
14. Keppel Hesselink JM. Exacerbation of Parkinson's disease by fluoxetine. Hum Psychopharmacol 1992;7:411-2.
15. Steur ENHJ. Increase of Parkinson disability after fluoxetine medication. Neurology 1993;43:211-3.
16. Meco G, Bonifati V, Fabrizio E, Vanacore N. Worsening of Parkinsonism with fluvoxamine - two cases. Hum Psychopharmacol 1994:9: 439-41.
17. Jiménez-Jiménez FJ, Tejeiro J, Martinez-Junquera G, Cabrera-Valdivia F, Alarcon J. Garcia-Albea E. Parkinsonism exacerbated by paroxetine. Neurology 1994:44:2406.
18. Holt WL ten, Klaassen CHL, Schrijver G. Ernstige hyponatriëmie, mogelijk door inadequate antidiuretisch-hormoonsecretie, bij gebruik van het antidepressivum fluoxetine. Ned Tijdschr Geneeskd 1994;138:1181-3.
19. Hwang AS, Magraw RM. Syndrome of inappropriate secretion of antidiuretic hormone due to fluoxetine [letter]. Am J Psychiatry 1989;146:399.
20. Chua TP, Vong SK. Hyponatraemia associated with paroxetine [letter]. BMJ 1993;306:143.
21. Llorente MD, Gorelick M, Silverman MA. Sertraline as the cause of inappropriate antidiuretic hormone secretion [letter]. J Clin Psychiatry 1994;55:543-4.